Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11857803 Diffusing alpha-emitter radiation therapy with enhanced beta treatment

Patent 11857803 was granted and assigned to Alpha Tau Medical on January, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Patent abstract

An interstitial source including a base suitable for implanting in a tumor and alpha emitting atoms attached to the base, with a concentration of at least 6 μCi per centimeter length. The alpha emitting atoms are attached to the base, with a desorption probability upon radioactive decay of not more than 30%.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11857803 Diffusing alpha-emitter radiation therapy with enhanced beta treatment

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo